0.00Open0.15Pre Close0 Volume46 Open Interest5.00Strike Price0.00Turnover74.51%IV14.76%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.2169Delta0.2675Gamma37.93Leverage Ratio-0.0064Theta-0.0008Rho-8.23Eff Leverage0.0043Vega
enVVeno Medical Stock Discussion
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical announced the presentation of new interim venous ulcer healing data from the VenoValve U.S. pivotal trial at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024. The data, presented by Dr. Cassius Iyad Ochoa Chaar of Yale School of Medici...
No comment yet